Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/202131
Title: | Impact of Advanced Age on the Incidence of Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stable Coronary Artery Disease in a Real-World Setting in Spain |
Author: | González Juanatey, Carlos Anguita Sánchez, Manuel Barrios, Vivencio Núñez Gil, Iván Gómez Doblas, Juan José García Moll, Xavier Lafuente Gormaz, Carlos Rollán Gómez, María Jesús Peral Disdier, Vicente Martínez Dolz, Luis Rodríguez Santamarta, Miguel Viñolas Prat, Xavier Soriano Colomé, Toni Muñoz Aguilera, Roberto Plaza, Ignacio Curcio Ruigómez, Alejandro Orts Soler, Ernesto Segovia Cubero, Javier Fanjul, Víctor Marín Corral, Judith Cequier, Ángel Savana Research Group |
Keywords: | Complicacions de la diabetis Malalties coronàries Persones grans Diabetes complications Coronary diseases Older people |
Issue Date: | 10-Aug-2023 |
Publisher: | MDPI AG |
Abstract: | Patients with type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD) without myocardial infarction (MI) or stroke are at high risk for major cardiovascular events (MACEs). We aimed to provide real-world data on age-related clinical characteristics, treatment management, and incidence of major cardiovascular outcomes in T2DM-CAD patients in Spain from 2014 to 2018. We used EHRead (R) technology, which is based on natural language processing and machine learning, to extract unstructured clinical information from electronic health records (EHRs) from 12 hospitals. Of the 4072 included patients, 30.9% were younger than 65 years (66.3% male), 34.2% were aged 65-75 years (66.4% male), and 34.8% were older than 75 years (54.3% male). These older patients were more likely to have hypertension (OR 2.85), angina (OR 1.64), heart valve disease (OR 2.13), or peripheral vascular disease (OR 2.38) than those aged <65 years (p < 0.001 for all comparisons). In general, they were also more likely to receive pharmacological and interventional treatments. Moreover, these patients had a significantly higher risk of MACEs (HR 1.29; p = 0.003) and ischemic stroke (HR 2.39; p < 0.001). In summary, patients with T2DM-CAD in routine clinical practice tend to be older, have more comorbidities, are more heavily treated, and have a higher risk of developing MACE than is commonly assumed from clinical trial data. |
Note: | Reproducció del document publicat a: https://doi.org/10.3390/jcm12165218 |
It is part of: | Journal of Clinical Medicine, 2023, vol. 12, num. 16 |
URI: | http://hdl.handle.net/2445/202131 |
Related resource: | https://doi.org/10.3390/jcm12165218 |
ISSN: | 2077-0383 |
Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
jcm-12-05218.pdf | 1.57 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License